Advertisement

Picture Berlin Partner German Biotech Days 2024 in Berlin 650x100px
Organisation › Details

Affluent Medical (Group)

Affluent Medical is a French MedTech company, founded by Truffle Capital, with the ambition to become a global leader in the treatment of structural heart diseases, which are the world's leading cause of mortality, and urinary incontinence, which currently affects one in four adults. Affluent Medical develops next-generation, mini-invasive, innovative, adjustable, and biomimetic implants to restore critical physiological functions. The product candidates developed by the Company are currently in preclinical and clinical studies. Kalios, the first mitral adjustable annuloplasty ring, should be the first Affluent Medical device to be marketed. Subject to raising the necessary funds to finance its strategy and to positive results from ongoing clinical studies, the Company's ambition is to gradually commercialize its products from the end of 2025/early 2026. *

 

Period Start 2018-02-06 merged
  Today Affluent Medical S.A.
  Predecessor Kephalios SAS
Products Industry medical device
  Industry 2 implant
Persons Person Ladet, Sébastien (Affluent Medical 202401 CEO)
  Person 2 Therin, Michel (Affluent Medical 202401 Board Chair)
     
  City n. a. 
    Address record changed: 2024-02-09
     
Basic data Employees n. a.
     
    * Document for »About Section«: Affluent Medical S.A.. (1/29/24). "Press Release: Affluent Medical Closes €3.5 Million Bridge via Capital Iincrease from Key Shareholders [not for US, CA, AU, or JP]". Aix-en-Provence.
     
   
Record changed: 2024-02-12

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Affluent Medical (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News Bayer Aignostics Collaboration 650x300px




» top